Authors: Reich, SH Johnson, T Wallace, MB Kephart, SE Fuhrman, SA Worland, ST Matthews, DA Hendrickson, TF Chan, F Meador, J Ferre, RA Brown, EL DeLisle, DM Patick, AK Binford, SL Ford, CE

Citation: Sh. Reich et al., Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis, and biological evaluation, J MED CHEM, 43(9), 2000, pp. 1670-1683

Authors: Matthews, DA Dragovich, PS Webber, SE Fuhrman, SA Patick, AK Zalman, LS Hendrickson, TF Love, RA Prins, TJ Marakovits, JT Zhou, R Tikhe, J Ford, CE Meador, JW Ferre, RA Brown, EL Binford, SL Brothers, MA DeLisle, DM Worland, ST

Citation: Da. Matthews et al., Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes, P NAS US, 96(20), 1999, pp. 11000-11007

Authors: Dragovich, PS Prins, TJ Zhou, R Webber, SE Marakovits, JT Fuhrman, SA Patick, AK Matthews, DA Lee, CA Ford, CE Burke, BJ Rejto, PA Hendrickson, TF Tuntland, T Brown, EL Meador, JW Ferre, RA Harr, JEV Kosa, MB Worland, ST

Citation: Ps. Dragovich et al., Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P-1 lactam moieties as L-glutamine replacements, J MED CHEM, 42(7), 1999, pp. 1213-1224